Regulatory Guidance

Amsterdam Beats Out Milan in EMA HQ Tie-Breaker

Nov 20, 2017

The European Medicines Agency (EMA) will relocate to Amsterdam in the Netherlands, a decision made after lots were drawn to break a tie with Milan, Italy, in the third and final round of voting.

The EMA, which has been based in London, UK, since it was established in 1995, will relocate as consequence of the UK’s withdrawal from the European Union. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam no later than March 30, 2019.

The relocation brought in a total of 19 bids from major cities throughout Europe. According to RAPS reporting, Milan (with 25 votes), Copenhagen and Amsterdam (with 20 votes each) advanced out of the first round of voting. In the second round, Milan (with 12 votes) and Amsterdam (with 9 votes) emerged as the top two prospects. Then, in the final round of voting, Milan and Amsterdam both tied with 13 votes each, sending the final vote to a drawing of lots.

Read the EMA press release